Alternatively, lower levels of SP1 induced by increased miR-29b expression leads to a reduced transcription of genes, known to promote AML leukemogenesis, such as modified and/or upregulated receptor tyrosine kinases (i.e., FLT3 and KIT) (81, 86). The gene discussed is FLT3; the disease is acute myeloid leukemia.